Colorectal Cancer, Childhood

Search Trials
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
Status:
Recruiting
Last Changed:
Jan 1, 1970
First Changed:
Oct 2, 2015
Disease(s):
Constitutional Mismatch Repair Deficiency Syndrome
Intervention(s):
Diffusion Tensor ImagingDiffusion Weighted ImagingDynamic Contrast-Enhanced Magnetic Resonance ImagingDynamic Susceptibility Contrast-Enhanced Magnetic Resonance ImagingLaboratory Biomarker AnalysisMagnetic Resonance Spectroscopic ImagingPembrolizumabPerfusion Magnetic Resonance Imaging
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
Status:
Terminated
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Colon Cancer
Intervention(s):
magnetic resonance imaging with positron emission tomography scanning
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
Status:
Completed
Last Changed:
May 6, 2013
First Changed:
Oct 1, 2005
Disease(s):
Childhood Burkitt Lymphoma
Intervention(s):
irinotecan hydrochlorideoxaliplatin
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Status:
Terminated
Last Changed:
Jan 1, 1970
First Changed:
Nov 7, 2007
Disease(s):
Cancer
Intervention(s):
cyclophosphamideCryoablation
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Status:
Completed
Last Changed:
Mar 7, 2018
First Changed:
Jan 1, 1970
Disease(s):
Advanced Malignant Mesothelioma
Intervention(s):
HIPEC OrientationConsultation with Survivorship NavigatorQuestionnaires

Connect. Empower. Inspire.